Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Intravitreal Brolucizumab for Pachychoroid Neovasculopathy Associated With Chronic Central Serous Chorioretinopathy.
Carosielli M; Carnevali A; Fallico M; Pirozzi E; Chiosi F; Chronopoulos A; Cucciniello P; Affatato M; Rapino G; dell'Omo R; BROCS study group; BROCS (BROlucizumab for the treatment of Central Serous chorioretinopathy) study group†.
Transl Vis Sci Technol
(Unknown)
Published: 2023
Risk Stratification for Diabetic Retinopathy Screening Order Using Deep Learning: A Multicenter Prospective Study.
Bora A; Tiwari R; Bavishi P; Virmani S; Huang R; Traynis I; Corrado GS; Peng L; Webster DR; Varadarajan AV; Pattanapongpaiboon W; Chopra R; Ruamviboonsuk P.
Transl Vis Sci Technol
(Unknown)
Published: 2023